Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids

Recruiting now

Conditions studied: Internal Hemorrhoid

In brief

This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.

Key facts

Study ID

NCT06106269

Run by

Mayo Clinic

People needed

20

Starts

2024-06-07

Expected to finish

2026-12-01

Last updated by the study team

2026-06-17

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Grade II or III hemorrhoidal disease as determined by a board-certified colorectal surgeon.
• Persistent or recurrent symptoms following hygiene and dietary measures or medication.
• Bleeding predominant ± pain symptoms.
• Undergoing planned rectal artery embolization (RAE) per standard clinical care.
• Male or female with age greater than 18 years, with the capacity and willingness to provide a written informed consent.
• Negative pregnancy test (if applicable).

You may not qualify if…

• Prior hemorrhoid surgery.
• Grade IV hemorrhoidal disease.
• Acute hemorrhoid complications.
• Chronic anal or perianal fissures.
• History of colorectal surgery or pelvic radiation.
• Inflammatory bowel disease.
• Portal hypertension or mesenteric venous congestion/occlusion.
• Inferior mesenteric artery (IMA) or internal iliac artery (IIA) stenosis or occlusion.
• Contraindication to iodinated contrast.
• Pregnant and/or breast-feeding subjects. A negative pregnancy test within 48 hours of the procedure per clinical care.

Where it is running

• Mayo Clinic Minnesota — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.